Glutamic Acid

Glutamic Acid

Global Glutamic Acid Market to Reach US$19.0 Billion by 2030

The global market for Glutamic Acid estimated at US$11.1 Billion in the year 2023, is expected to reach US$19.0 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$14.6 Billion by the end of the analysis period. Growth in the Animal Feed Application segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 8.9% CAGR

The Glutamic Acid market in the U.S. is estimated at US$1.6 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.1 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global Glutamic Acid Market - Key Trends & Drivers Summarized

Glutamic acid, a non-essential amino acid, plays a pivotal role in various physiological processes in the human body. It is one of the 20 amino acids used to synthesize proteins and is crucial for proper cell function. Glutamic acid is a key neurotransmitter in the central nervous system, involved in cognitive functions such as learning and memory. It also serves as a metabolic intermediate in the citric acid cycle, which is fundamental for energy production. This amino acid is prevalent in both plant and animal proteins, with significant amounts found in foods like meat, poultry, fish, eggs, dairy products, and certain vegetables. Beyond its biological significance, glutamic acid is widely used in the food industry, particularly in the form of its sodium salt, monosodium glutamate (MSG), as a flavor enhancer due to its ability to impart the umami taste.

The industrial production of glutamic acid is primarily achieved through microbial fermentation, a method that has been optimized over the years to increase yield and reduce costs. This process involves the use of genetically modified strains of bacteria such as Corynebacterium glutamicum, which efficiently convert glucose or other carbon sources into glutamic acid. The demand for glutamic acid has seen a steady increase, driven by its extensive application in the food industry as well as in pharmaceuticals and cosmetics. In pharmaceuticals, glutamic acid is used in formulations for treating neurological disorders, while in cosmetics, it is valued for its moisturizing and skin-conditioning properties. The growing consumer awareness regarding health and wellness has further boosted the demand for natural flavor enhancers like MSG, reinforcing the significance of glutamic acid in the market.

The growth in the glutamic acid market is driven by several factors, including the rising demand for processed and convenience foods, where MSG is commonly used to enhance flavor. Technological advancements in fermentation processes have significantly improved the efficiency of glutamic acid production, making it more cost-effective and accessible. Additionally, the expanding pharmaceutical industry’s need for amino acid-based drugs and supplements has spurred demand. Consumer trends toward natural and clean-label products have also contributed to the market growth, as glutamic acid and its derivatives are considered natural ingredients. Moreover, the increasing application of glutamic acid in animal feed to enhance the nutritional value and growth performance of livestock is another critical growth driver. The ongoing research into the health benefits of glutamic acid, particularly its role in brain health and metabolism, is expected to further propel its market demand.

Select Competitors (Total 53 Featured) -

• Evonik Industries AG
• Ajinomoto Co., Inc.
• AnaSpec, Inc.
• Global Bio-Chem Technology Group Co., Ltd.
• Bachem AG
• AMCO Proteins
• Clariant AG
• Amino GmbH
• Central Drug House (P) Ltd.
• Chaitanya Biologicals Pvt., Ltd.
• Devson Impex Pvt., Ltd.
• Hefei TNJ Chemical Industry Co., Ltd.
• AF Biochem
• Calzyme Laboratories, Inc.
• Avanscure Lifesciences Private Limited

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.